Zoetis Acquires Basepaws

June 7, 2022

Zoetis Inc. has acquired Basepaws, a Los Angeles–based petcare genetics company that offers at-home feline DNA and oral microbiome tests and analytics. The acquisition strengthens Zoetis' precision animal health portfolio and brings Basepaws' feline genomic and microbiome database and testing capabilities into Zoetis' R&D and product pipeline; financial terms were not disclosed.

Buyers
Zoetis Inc.
Targets
Basepaws
Industry
Veterinary
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.